Overview

Dose Response Study of Inhaled Ciclesonide (Glucocorticosteroid) to Patients With Persistent Asthma

Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
To investigate the efficacy and safety of ciclesonide inhaled into the lungs in a range of doses in a new dry powder inhaler compared to ciclesonide inhaled into the lungs using a metered dose inhaler
Phase:
Phase 2
Details
Lead Sponsor:
Sanofi
Treatments:
Ciclesonide